Annual Total Liabilities
$114.81 M
+$33.22 M+40.72%
December 31, 2023
Summary
- As of February 12, 2025, CORT annual total liabilities is $114.81 million, with the most recent change of +$33.22 million (+40.72%) on December 31, 2023.
- During the last 3 years, CORT annual total liabilities has risen by +$66.42 million (+137.25%).
- CORT annual total liabilities is now at all-time high.
Performance
CORT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$145.42 M
+$27.11 M+22.91%
September 30, 2024
Summary
- As of February 12, 2025, CORT quarterly total liabilities is $145.42 million, with the most recent change of +$27.11 million (+22.91%) on September 30, 2024.
- Over the past year, CORT quarterly total liabilities has increased by +$37.35 million (+34.56%).
- CORT quarterly total liabilities is now at all-time high.
Performance
CORT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CORT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.7% | +34.6% |
| 3 y3 years | +137.3% | +78.2% |
| 5 y5 years | +220.6% | +78.2% |
CORT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +139.4% | at high | +203.3% |
| 5 y | 5-year | at high | +179.1% | at high | +303.9% |
| alltime | all time | at high | +6194.5% | at high | >+9999.0% |
Corcept Therapeutics Incorporated Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $145.42 M(+22.9%) |
| Jun 2024 | - | $118.31 M(+9.5%) |
| Mar 2024 | - | $108.07 M(-5.9%) |
| Dec 2023 | $114.81 M(+40.7%) | $114.81 M(-13.2%) |
| Sep 2023 | - | $132.34 M(+28.5%) |
| Jun 2023 | - | $103.01 M(+16.7%) |
| Mar 2023 | - | $88.26 M(+8.2%) |
| Dec 2022 | $81.59 M(+70.2%) | $81.59 M(+36.2%) |
| Sep 2022 | - | $59.89 M(+10.8%) |
| Jun 2022 | - | $54.04 M(-10.4%) |
| Mar 2022 | - | $60.31 M(+25.8%) |
| Dec 2021 | $47.95 M(-0.9%) | $47.95 M(+6.2%) |
| Sep 2021 | - | $45.17 M(-1.4%) |
| Jun 2021 | - | $45.80 M(+10.1%) |
| Mar 2021 | - | $41.60 M(-14.0%) |
| Dec 2020 | $48.39 M(+17.7%) | $48.39 M(+8.9%) |
| Sep 2020 | - | $44.45 M(+0.7%) |
| Jun 2020 | - | $44.13 M(+22.6%) |
| Mar 2020 | - | $36.01 M(-12.5%) |
| Dec 2019 | $41.13 M(+14.8%) | $41.13 M(+26.0%) |
| Sep 2019 | - | $32.65 M(+6.6%) |
| Jun 2019 | - | $30.63 M(-11.1%) |
| Mar 2019 | - | $34.46 M(-3.8%) |
| Dec 2018 | $35.81 M(+21.1%) | $35.81 M(-10.9%) |
| Sep 2018 | - | $40.21 M(+30.2%) |
| Jun 2018 | - | $30.87 M(+11.3%) |
| Mar 2018 | - | $27.75 M(-6.2%) |
| Dec 2017 | $29.57 M(+8.0%) | $29.57 M(+21.3%) |
| Sep 2017 | - | $24.37 M(+19.5%) |
| Jun 2017 | - | $20.39 M(-20.8%) |
| Mar 2017 | - | $25.76 M(-5.9%) |
| Dec 2016 | $27.37 M(-18.1%) | $27.37 M(-13.6%) |
| Sep 2016 | - | $31.68 M(+1.6%) |
| Jun 2016 | - | $31.18 M(-4.8%) |
| Mar 2016 | - | $32.74 M(-2.0%) |
| Dec 2015 | $33.40 M(-12.1%) | $33.40 M(-4.3%) |
| Sep 2015 | - | $34.90 M(-5.2%) |
| Jun 2015 | - | $36.83 M(-2.2%) |
| Mar 2015 | - | $37.65 M(-1.0%) |
| Dec 2014 | $38.02 M | $38.02 M(-1.2%) |
| Sep 2014 | - | $38.48 M(-6.0%) |
| Jun 2014 | - | $40.94 M(-5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $43.46 M(+3.3%) |
| Dec 2013 | $42.06 M(+12.5%) | $42.06 M(+4.4%) |
| Sep 2013 | - | $40.28 M(+2.5%) |
| Jun 2013 | - | $39.32 M(+5.9%) |
| Mar 2013 | - | $37.14 M(-0.7%) |
| Dec 2012 | $37.39 M(+643.9%) | $37.39 M(+10.4%) |
| Sep 2012 | - | $33.87 M(+482.4%) |
| Jun 2012 | - | $5.82 M(+62.9%) |
| Mar 2012 | - | $3.57 M(-29.0%) |
| Dec 2011 | $5.03 M(+30.2%) | $5.03 M(+85.3%) |
| Sep 2011 | - | $2.71 M(-29.6%) |
| Jun 2011 | - | $3.86 M(+20.7%) |
| Mar 2011 | - | $3.20 M(-17.2%) |
| Dec 2010 | $3.86 M(+59.6%) | $3.86 M(+35.0%) |
| Jun 2010 | - | $2.86 M(+33.4%) |
| Mar 2010 | - | $2.14 M(-11.4%) |
| Dec 2009 | $2.42 M(-15.7%) | $2.42 M(+2.6%) |
| Sep 2009 | - | $2.36 M(+10.2%) |
| Jun 2009 | - | $2.14 M(-34.9%) |
| Mar 2009 | - | $3.29 M(+14.6%) |
| Dec 2008 | $2.87 M(-4.7%) | $2.87 M(-13.0%) |
| Sep 2008 | - | $3.29 M(+70.8%) |
| Jun 2008 | - | $1.93 M(-17.0%) |
| Mar 2008 | - | $2.32 M(-22.8%) |
| Dec 2007 | $3.01 M(-15.0%) | $3.01 M(+12.2%) |
| Sep 2007 | - | $2.68 M(+86.0%) |
| Jun 2007 | - | $1.44 M(-35.1%) |
| Mar 2007 | - | $2.22 M(-37.3%) |
| Dec 2006 | $3.54 M(-0.6%) | $3.54 M(-37.5%) |
| Sep 2006 | - | $5.67 M(+8.9%) |
| Jun 2006 | - | $5.20 M(-0.6%) |
| Mar 2006 | - | $5.23 M(+46.9%) |
| Dec 2005 | $3.56 M(+95.3%) | $3.56 M(+31.9%) |
| Sep 2005 | - | $2.70 M(+78.5%) |
| Jun 2005 | - | $1.51 M(+20.0%) |
| Mar 2005 | - | $1.26 M(-30.9%) |
| Dec 2004 | $1.82 M(-95.8%) | $1.82 M(+11.6%) |
| Sep 2004 | - | $1.63 M(+16.7%) |
| Jun 2004 | - | $1.40 M(-96.8%) |
| Mar 2004 | - | $43.77 M(+1.2%) |
| Dec 2003 | $43.25 M(-1.1%) | $43.25 M |
| Dec 2002 | $43.73 M(+2221.4%) | - |
| Dec 2001 | $1.88 M | - |
FAQ
- What is Corcept Therapeutics Incorporated annual total liabilities?
- What is the all time high annual total liabilities for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual total liabilities year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly total liabilities?
- What is the all time high quarterly total liabilities for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly total liabilities year-on-year change?
What is Corcept Therapeutics Incorporated annual total liabilities?
The current annual total liabilities of CORT is $114.81 M
What is the all time high annual total liabilities for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual total liabilities is $114.81 M
What is Corcept Therapeutics Incorporated annual total liabilities year-on-year change?
Over the past year, CORT annual total liabilities has changed by +$33.22 M (+40.72%)
What is Corcept Therapeutics Incorporated quarterly total liabilities?
The current quarterly total liabilities of CORT is $145.42 M
What is the all time high quarterly total liabilities for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly total liabilities is $145.42 M
What is Corcept Therapeutics Incorporated quarterly total liabilities year-on-year change?
Over the past year, CORT quarterly total liabilities has changed by +$37.35 M (+34.56%)